TRIUMPH-4 (NCT05931367): 68-week standalone knee osteoarthritis trial, adults with obesity/overweight without diabetes (N=445, randomized 1:1:1 to 9mg, 12mg, or placebo)
Long-Term Health Improvements In terms of diabetes management, semaglutide can lead to a noticeable improvement in A1C levelsa measure of blood sugar management over the previous three monthswithin four to six months of regular treatment
Access this article Similar content being viewed by others References Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB
doi: 10.1074/jbc.271.46.28984
The minimalist background ensures no distractions, drawing all attention to the product and the bold, straightforward headline: "Ping it